Sally Beauty (NYSE:SBH) Hits New 1-Year High - Here's What Happened

Key Points

• Sally Beauty Holdings, Inc. (NYSE:SBH) reached a new 52-week high of $16.47 and closed at $16.31, with over 2.35 million shares traded.
• Analysts have presented mixed ratings, with the consensus rating being "Moderate Buy" and a target price averaging $13.88, while recent reports show target prices as high as $19.00.
• The company reported better-than-expected earnings of $0.51 per share for the last quarter, surpassing estimates by $0.09, despite a year-over-year revenue decline of 1.0%.

Sally Beauty Holdings, Inc. (NYSE:SBH - Get Free Report)'s stock price reached a new 52-week high on Thursday . The stock traded as high as $16.47 and last traded at $16.31, with a volume of 2357313 shares trading hands. The stock had previously closed at $16.28.

Analyst Ratings Changes

SBH has been the subject of several recent research reports. TD Cowen lifted their target price on shares of Sally Beauty from $13.00 to $16.00 and gave the company a "buy" rating in a report on Thursday, September 4th. Canaccord Genuity Group lifted their price target on shares of Sally Beauty from $15.00 to $19.00 and gave the company a "buy" rating in a research note on Monday, September 15th. Cowen reissued a "buy" rating on shares of Sally Beauty in a research note on Thursday, September 4th. Zacks Research raised shares of Sally Beauty from a "hold" rating to a "strong-buy" rating in a research note on Friday, September 5th. Finally, Wall Street Zen cut shares of Sally Beauty from a "buy" rating to a "hold" rating in a research note on Sunday, September 21st. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $13.88.

Sally Beauty Stock Performance

The company has a debt-to-equity ratio of 1.16, a quick ratio of 0.49 and a current ratio of 2.41. The firm's 50 day simple moving average is $13.52 and its 200-day simple moving average is $10.47. The company has a market cap of $1.61 billion, a price-to-earnings ratio of 8.77 and a beta of 1.34.

Sally Beauty (NYSE:SBH - Get Free Report) last announced its earnings results on Tuesday, August 5th. The specialty retailer reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.09. Sally Beauty had a net margin of 5.26% and a return on equity of 28.11%. The company had revenue of $933.31 million for the quarter, compared to analysts' expectations of $928.78 million. During the same quarter in the previous year, the company posted $0.45 EPS. The firm's quarterly revenue was down 1.0% on a year-over-year basis. Sally Beauty has set its FY 2025 guidance at EPS. On average, sell-side analysts predict that Sally Beauty Holdings, Inc. will post 1.81 EPS for the current year.

Insiders Place Their Bets

In other Sally Beauty news, Director Max R. Rangel bought 3,500 shares of the stock in a transaction on Thursday, September 4th. The shares were bought at an average price of $14.07 per share, with a total value of $49,245.00. Following the purchase, the director directly owned 3,500 shares in the company, valued at $49,245. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Denise Paulonis bought 4,500 shares of the stock in a transaction on Friday, August 8th. The shares were acquired at an average cost of $11.74 per share, for a total transaction of $52,830.00. Following the purchase, the chief executive officer owned 366,865 shares in the company, valued at $4,306,995.10. The trade was a 1.24% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 10,500 shares of company stock valued at $132,125 in the last 90 days. 1.56% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of SBH. Arrowstreet Capital Limited Partnership raised its holdings in shares of Sally Beauty by 2,768.7% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,220,160 shares of the specialty retailer's stock worth $11,299,000 after acquiring an additional 1,177,626 shares during the period. Invenomic Capital Management LP raised its holdings in shares of Sally Beauty by 160.3% during the 1st quarter. Invenomic Capital Management LP now owns 1,889,310 shares of the specialty retailer's stock worth $17,060,000 after acquiring an additional 1,163,619 shares during the period. Nuveen LLC purchased a new position in shares of Sally Beauty during the 1st quarter worth $8,600,000. Ranmore Fund Management Ltd raised its holdings in shares of Sally Beauty by 54.6% during the 2nd quarter. Ranmore Fund Management Ltd now owns 2,196,020 shares of the specialty retailer's stock worth $20,335,000 after acquiring an additional 776,020 shares during the period. Finally, CenterBook Partners LP raised its holdings in Sally Beauty by 359.3% in the 1st quarter. CenterBook Partners LP now owns 961,230 shares of the specialty retailer's stock valued at $8,680,000 after buying an additional 751,943 shares during the period.

Sally Beauty Company Profile

Sally Beauty Holdings, Inc operates as a specialty retailer and distributor of professional beauty supplies. The company operates through two segments, Sally Beauty Supply and Beauty Systems Group. The Sally Beauty Supply segment offers beauty products, including hair color and care products, skin and nail care products, styling tools, and other beauty products for retail customers, salons, and salon professionals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.